Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues Patricia M. Danzon Current Opinion 30 July 2018 Pages: 1395 - 1405
Multi-Indication Pricing: Nice in Theory but Can it Work in Practice? Jorge Mestre-FerrandizNéboa ZozayaÁlvaro Hidalgo-Vega Current Opinion 10 September 2018 Pages: 1407 - 1420
Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models Anthony J. HatswellAsh BullementMatthew D. Stevenson Practical Application 27 July 2018 Pages: 1421 - 1426
Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Iñigo BermejoShijie RenMatt Stevenson Review Article 08 June 2018 Pages: 1427 - 1437
The Future of Precision Medicine: Potential Impacts for Health Technology Assessment James Love-KohAlison PeelMatthew Taylor Original Research Article Open access 13 July 2018 Pages: 1439 - 1451
Understanding and Identifying Key Issues with the Involvement of Clinicians in the Development of Decision-Analytic Model Structures: A Qualitative Study Samantha HusbandsSusan JowettJoanna Coast Original Research Article 17 August 2018 Pages: 1453 - 1462
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia Mark BounthavongJaved ButlerDavid L. Veenstra Original Research Article Open access 08 September 2018 Pages: 1463 - 1473
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea Yun-Kyung KimJoon Young SongEuna Han Original Research Article Open access 25 September 2018 Pages: 1475 - 1490